During dorsal closure the lateral epithelia on each side of the embryo migrate dorsally over the amnioserosa and fuse at the dorsal midline. Detailed genetic studies have revealed that many molecules are involved in this epithelial sheet movement, either with a signaling function or as structural or motor components of the process. Here we report the characterization of cabut (cbt), a new Drosophila gene involved in dorsal closure. cbt is expressed in the yolk sac nuclei and in the lateral epidermis. The Cbt protein contains three C 2 H 2 -type zinc fingers and a serine-rich domain, suggesting that it functions as a transcription factor. cbt mutants die as embryos with dorsal closure defects. Such embryos show defects in the elongation of the dorsal-most epidermal cells as well as in the actomyosin cable assembly at the leading edge. A combination of molecular and genetic analyses demonstrates that cbt expression is dependent on the JNK cascade during dorsal closure, and it functions downstream of Jun regulating dpp expression in the leading edge cells.
INTRODUCTION
During Drosophila embryogenesis, dorsal closure, germband retraction, and head involution compose the major morphogenetic movements that participate in organogenesis of the first instar larva. Dorsal closure (DC) is the last of these movements that occurs following germband retraction. At the onset of closure, the epidermis of the Drosophila embryo has a hole on its dorsal side that is occupied by the amnioserosa, an epithelium of large flat cells that do not contribute to the larva. During DC, the lateral epithelia on each side of the embryo migrate dorsally over the amnioserosa and fuse at the dorsal midline. This process involves dramatic and coordinated morphological changes of both the epidermal and amnioserosal cells . Recent studies have demonstrated that an extraembryonic tissue, the yolk sac, also contributes to DC (Narasimha and Brown, 2004; Reed et al., 2004) .
The movement of the epidermal sheets is directed by the dorsal most row of epidermal cells, which are in contact with the amnioserosa (Noselli and Agnes, 1999) . At the beginning of DC, these dorsal-most epithelial (DME) cells elongate along the dorsoventral (D-V) axis of the embryo. This seems to be achieved by the accumulation of large quantities of filamentous actin (F-actin) and non muscle myosin at their interface with the amnioserosa, which is known as the leading edge (Young et al., 1993) . First, the accumulation of actin occurs between cells at the level of adherens junctions, but later on, a cable of actin and myosin assembles across the leading edge (LE), and F-actin is incorporated into dynamic protrusions (Kaltschmidt et al., 2002) . It seems that actin dynamics at the LE is preceded by the planar polarization of the DME cells associated with a reorganization of the cytoskeleton. This is reflected by the redistribution of several cell-surface-associated proteins in the plane of the epithelium that occurs towards the end of DC. For example, the distribution of the septatejunction-associated proteins Disc large (Dlg) and Fasciclin III (FasIII) changes as DC occurs.
At the beginning of DC they are distributed symmetrically around the epidermal cells, but as closure progresses they clear from the apical membrane facing the LE. The planar polarization of these cells is essential for DC since in its absence the process occurs abnormally (Kaltschmidt et al., 2002) .
During DC cell shape changes in the amnioserosa begin with apical constriction of cells at the anterior and posterior ends of the tissue. The middle cells in between the two clusters also change shape since they are first elongated perpendicular to the A-P axis of the embryo, but at the end of DC they are both elongated along the A-P axis and apically constricted (Harden et al., 2002) . This cell shape change is accompanied by an invagination of the tissue. Laser ablation experiments show that the amnioserosa is not passively squeezed by the advancing epithelial sheets, but exerts some tension that helps to draw them together (Kiehart et al., 2000) . Recently, it has been shown that the basal surface of the amnioserosa is in close apposition with the yolk sac membrane. This intimate contact between these two extraembryonic tissues is mediated by integrins and prevents premature anoikis of the amnioserosa, suggesting that the yolk cell contributes to dorsal closure since it is essential for amnioserosa survival (Narasimha and Brown, 2004; Reed et al., 2004) .
Genetic analyses have identified numerous genes required for DC. DC mutants die during embryogenesis and present various shapes and sizes of holes in cuticle preparations of the resulting larvae (Jacinto and Martin, 2001 ). Molecular analyses of these genes have revealed that some of them encode gene products that are structural and motor components of the process. That is the case of zipper (zip) or canoe (cno), which code for the motor protein nonmuscle myosin II and an adherens-junction-associated protein, respectively (Miyamoto et al., 1995; Young et al., 1993) . Besides, several signaling pathways like the Jun N-terminal kinase (JNK) cascade and Wg signaling are also important in regulating the initiation and maintenance of epithelial movements associated with DC (reviewed by Harden, 2002) . Prior to DC the JNK signaling cascade is active in both the amnioserosa and the LE of the epidermis (Reed et al., 2001) . Later on, it is downregulated in the amnioserosa but not in the LE cells, activating the localized transcription of two target genes: dpp and a dual specifity phosphatase, puckered (puc) (Glise and Noselli, 1997; Martín-Blanco et al., 1998; RiesgoEscovar and Hafen, 1997; Zeitlinger et al., 1997) . It has been recently proposed that a subsequent activation of JNK signaling in the amnioserosa could trigger the disintegration and death of this tissue after closure of the epidermis (Reed et al., 2004) . Besides, several studies of DC in embryos with impaired JNK and Wg signaling have also shown that both are essential for actin dynamics and cytoskeletal organization of the DME cells, but only Wg signaling seems to be required for the polarization of epidermal cells in the initial phases of DC (Kaltschmidt et al., 2002; McEwen et al., 2000; Morel and Martinez-Arias, 2004; Ricos et al., 1999) .
In this paper, we report the identification and genetic analysis of cabut (cbt), a novel gene implicated in Drosophila embryogenesis. It is expressed in the yolk cell and in the lateral epidermis, and encodes a putative transcription factor containing C2H2 zinc finger motifs.
Phenotypic analyses of cbt mutant embryos show that loss of Cbt function affects several key events in DC: cell shape change in the epidermis, cytoskeleton activity, JNK signaling, and occasionally polarity of the DME cells. Taken together, our results indicate that cbt has a role in DC, downstream of the JNK cascade, regulating dpp expression at the LE.
MATERIALS AND METHODS

Fly strains
The EP line EP(2)2237 (Rørth et al., 1998) was used for the characterization of the cbt locus.
We mobilized the EP element in that line using the Sp/CyO; Sb, ∆2-3/TM6, Ubx stock as external source of transposase and several imprecise lethal excisions were recovered. The Tp(2;1)odd 1.10 transposition line (Nusslein-Volhard et al., 1985) was used to confirm the genomic location of the excision alleles.
The UAS-cbt wild type construct was obtained by cloning the SD06353 cDNA into the pUAST Drosophila transformation vector (Brand and Perrimon, 1993) . P-element-mediated
Drosophila germ-line transformation of this construct was performed as described (Spradling and Rubin, 1982) .
The following GAL4 and UAS lines were also used: 69B-GAL4, da-GAL4 (both from Bloomington), en-GAL4 (Tabata et al., 1995) , arm-GAL4 (Sanson et al., 1996) , P0180-
GAL4 (Narashima et al., 2004), UAS-Hep
ACT (Weber et al., 2000) , UAS-dpp (a gift from S.
Casas). The mutant alleles used in this work are: bsk 2 (Sluss et al., 1996) , jun 2 (NussleinVolhard et al., 1984) , mys 1 (Digan et al., 1986) , puc E69 (Ring and Martinez-Arias, 1993 ) and bsg B39.1M2 (Reed et al., 2004) .
To distinguish the cbt EP(2)2237E1
and cbt
EP(2)2237E28
homozygous mutant embryos from their heterozygous siblings, we made use of balancer chromosomes carrying a lacZ (CyO,wg-lacZ; Ingham et al., 1991) or a GFP (CyO,ubi-GFP; Bloomington) transgene.
Molecular analyses
The exact point of the EP element insertion in the EP(2)2237 line was determined by inverse PCR as described in the BDGP web site. PCR products were cloned in TOPO 2.1 (Invitrogen) and sequenced. Searches in Drosophila databases using those sequences identified several ESTs within the immediate vicinity of the EP insertion. Two of them were selected for sequence analysis: LD06353 and SD05727. We fully sequenced LD06353 (GenBank accession no. AJ749862), which corresponds to the cbt-RA isoform. Partial sequencing of SD05727 revealed that it is identical in sequence to SD05726 (data not shown) and corresponds to the cbt-RB isoform. To determine the exon-intron structure of cbt, we compared the genomic and the ESTs sequences from BDGP, and also the cDNA sequences determined by us. We found 23 ESTs derived from the cbt gene: 20 correspond to the cbt-RA isoform, two correspond to the cbt-RB isoform, and one is a partial sequence that could correspond to either of them.
To determine the molecular lesion present in the mutants, we performed single-embryo homozygous embryos.
In situ hybridization
In situ hybridizations to whole-mount embryos were performed as described (Tautz and Pfeifle, 1989) . In situ hybridizations to imaginal discs were done following the protocol described by Cheung et al. (1992) with several modifications. Antisense RNA probes were generated with the DIG RNA labeling kit SP6/T7 (Roche). The wild-type cbt expression pattern was determined in OrR embryos using the SD06353 cDNA as template for riboprobe synthesis. A complete dpp cDNA (Lockwood and Bodmer, 2002 ) was used to generate dpp antisense riboprobes. Sense probes generated in parallel with the same templates were used as negative controls in all cases.
RT-PCR and Northern blot
Total RNA was isolated from 0-22h embryos using homozygous embryos and arm-GAL4/UAS-cbt embryos was separated by formaldehyde gel electroforesis and blotted onto a positively charged nylon membrane (Roche). cbt and RP49 antisense RNA probes were generated as described. Hybridization and washes were performed as described by the supplier (Roche). The blots were detected immunochemically with CDP-Star (Roche).
Embryo phenotypic analysis
Embryos for SEM were prepared as described , except that the vitelline membrane was removed using heptane-methanol 1:1. Specimens were imaged on a Hitachi S-2500 scanning electron microscope. For cuticle analysis, embryos were collected during 24 h and aged an additional 24 h, then they were dechorionated in commercial bleach for 3 minutes, and the vitelline membrane removed using heptane-methanol 1:1. After several washes in methanol, embryos were mounted in Hoyer´s-lactic acid 1:1 and allowed to clear at 65ºC overnight. Some homozygous mutant embryos showed a bigger head than wild types.
This led us to name this gene cabut, which means "bigheaded" in the dialect of Valencia.
These "bigheaded" embryos have a very weak dorsal-open phenotype.
Embryonic lethality assays
The embryonic lethality rescue of the cbt
homozygous mutant overexpressing UAScbt was performed using several GAL4 lines (X-GAL4, were X can be 69B, da or P0180; all on the third chromosome and homozygous viable homozygous mutant overexpressing UAS-dpp was performed similarly, but using only the 69B-GAL4.
To test for genetic interactions between cbt and hep, we performed the following cross: allele. If cbt is downstream of hep, the embryonic lethality will be reduced. As all the embryos that overexpress Hep Act die, we can calculate the embryonic lethality due to the genetic interaction as: 100-[(50%-observed % embryonic lethality)/25% x 100] ( Table 2) .
Histology and immunohistochemistry
Embryos were fixed and stained using standard protocols. Fixation was carried out using 4%
parafolmaldehyde diluted in PBS and desvitellinization in heptane-methanol 1:1. We used the kit. Anti-β-galactosidase and in situ hydridization double stainings were done as described (Manoukian and Kraus, 1992) .
RESULTS
Molecular characterization of cabut
cabut (cbt) was identified in a modular misexpression screen of 2200 different EP lines (Rørth et al., 1998) looking for genes involved in the establishment of epithelial planar cell polarity, as an insertion (EP(2)2237) that caused planar polarity defects in the eye, wing and thorax when expressed under the control of sev-GAL4 and ap-GAL4, respectively (Marek Mlodzik and N.P., unpublished). To identify the gene overexpressed by EP(2)2237, we cloned and sequenced the adjacent DNA and identified corresponding ESTs in the BDGP database.
EP (2) protein of 428 amino acids that contains a serine-rich region at the amino terminus, and three classical zinc finger domains C 2 H 2 type at the carboxy-terminal region ( Fig. 1C) , which are located in tandem and match the consensus sequence described as CX 2-4 CX 12 HX 2-6 H (Iuchi, 2001 ). An alignment of the three Zn fingers found in the Cbt protein is shown in Fig. 1D .
Database searches identified many proteins with similar domains and from many different organisms (data not shown), most of them classified as Sp1-like transcription factors, Krüppel-like factors, TGFβ inducible early growth response proteins or BTE-binding proteins. In general, proteins with three C 2 H 2 zinc fingers may bind DNA, RNA or proteins through the fingers, although most of them are DNA-binding proteins that, together with other factors, participate in controlling transcription of target genes (Iuchi, 2001) . Thus, the probable role of Cbt is to bind to specific regions of DNA and to regulate gene expression.
Expression of cbt in embryos and imaginal discs
The spatial expression pattern of cbt in embryos and imaginal discs was examined by wholemount in situ hybridization with a cbt-RA RNA probe. The initial expression of cbt is observed at the cellular blastoderm stage in an ubiquitous manner ( Fig. 2A) . This ubiquitous expression persists till stage 8. Then, at stage 9 cabut is mainly expressed in the gut primordium and also in the epidermis (data not shown). During stage 11 and onwards, cabut is expressed in the yolk cell nuclei and in the lateral epidermis (Figs. 2B-C). cbt expression in the yolk cell has been confirmed by using an enhancer trap line in the basigin (bsg) gene (Fig.   2C ), which is expressed in that tissue (Reed et al., 2004) . Moreover, cbt transcripts can also be detected in the posterior gut ( Fig. 2B ). At later stages, when the yolk cell is included in the gut, expression of cbt is also present there. In third instar larvae, cbt expression is largely ubiquitous in all imaginal discs (data not shown). Similar hybridization experiments performed with RNA probes specific for the cbt-RB isoform yielded negative results. To confirm this, we performed RT-PCR experiments designed to distinguish between cbt-RA and cbt-RB isoforms in different stages of development. We could only detect cbt products when using primers specific for the cbt-RA isoform (data not shown). This indicates that the cbt-RB variant (indeed represented by only two ESTs in the BDGP, see Material and methods) probably corresponds to an artifact generated during cDNA preparation.
Genetics of the cbt locus
To generate cbt mutations we took advantage of the EP(2)2237 element inserted in the upstream region of cbt, which is homozygous viable. Several lethal excisions were obtained after mobilization of the EP element, and two of them (cbt
EP(2)2237E1
EP(2)2237E28
) were used for further analyses. In order to identify the molecular lesions causing the lethality of those excisions, we amplified and sequenced the coding region of cbt from embryos homozygous for both alleles, finding in cbt EP(2) embryos, since we failed to amplify a genomic region between 3.9 and 4,9 kb upstream of the cbt transcription start site ( Supplementary Fig. 1 ). To demonstrate whether these mutations were affecting cbt expression, we performed in situ hybridization experiments. cbt expression was almost lost in cbt EP(2)2237 E1 homozygous embryos, although it is weakly detected in the gut (Fig. 2D ). In cbt
homozygous embryos cbt expression was present in the epidermis and gut, but not in the yolk cell (Fig. 2E ). These results were confirmed by Northern blot analyses using cbt specific probes. While in cbt
embryos cbt transcripts are weakly detected, in cbt
embryos the level of expression of the gene is almost wild type (Fig, 2F) . In control embryos we detect only a 2-kb transcript corresponding to the cbt-RA isoform, thus confirming the results obtained by RT-PCR (see above). Our results suggest that the cbt EP(2)2237E1 mutation is probably affecting an enhancer element necessary for cbt expression, and can be considered a cbt loss-of-function allele.
However, cbt EP(2)2237 E28 appears to be a very weak allele, in which cbt expression is only reduced.
We also wanted to confirm genetically that the cbt genomic region was affected in both excision lines. To do that we used the transposition line Tp(2;1)odd 1.10 , in which the cbt genomic region is transposed to the X chromosome (Nusslein-Volhard et al., 1985) . We found that males heterozygous for any of both cbt alleles, and carrying the deficiency but not the transposition, were lethal. All these results are consistent with the notion that the both mutations affect the cbt genomic region and disrupts cbt activity. Fig. 3G ). By the end of embryonic development we see embryos with dorsal holes (data not shown), and others in which internal organs are extruded (Fig.   3H ), due to an improper closure of these embryos.
Loss of cbt function is associated with defects in dorsal closure during embryogenesis
To demonstrate that the lethality observed in cbt
mutant embryos is caused by loss of cbt activity, we attempted to rescue it by overexpressing cbt with da-GAL4 (an ubiquitous driver). Confirming our assumption, we found that ubiquitous cbt overexpression results in a 50.2% of rescue (Table 1) . Since cbt is expressed in the epidermis and the yolk cell during embryogenesis, we wanted to test its requirement in both tissues. Similar lethality rescue experiments of cbt EP(2)2237E1 mutant embryos were performed by overexpressing cbt either with 69B-GAL4 (an epidermal driver) or with P0180-GAL4 (a driver specific for the yolk cell). Overexpression of cbt in the epidermis results in a 100% of rescue. However, the lethality is partially rescued when cbt is overexpressed in the yolk cell (see Table 2) suggesting that cbt activity is mainly required in the epidermis for proper embryonic development.
Loss of cbt function affects cell shape changes in the epidermis but not in the amnioserosa
During DC, cells in the epidermis and the amnioserosa undergo shape changes and movements. Moreover, the DME cells polarize in the plane of the epithelium. To determine whether a failure in these events could be the cause of closure defects observed in cbt mutants, we stained cbt EP(2)2237 E1 mutant embryos for markers that allowed us to analyze cell shape and polarity in the dorsal ectoderm. Dlg and FasIII inmunostainings of those embryos revealed that the elongation in the D-V axis of DME cells, and more lateral epidermal cells, initiates properly but fails shortly afterwards. In consequence, those cells do not elongate to the same extent as in wild-type embryos, and round up (Figs. 4A-D) . Moreover, we see that occasionally the distribution of Dlg and FasIII in the DME cells is not polarized, since it does not disappear from the apical part of the cells. Thus elongation and, in some cases, planar polarization of the DME cells do not occur properly in cbt mutant embryos.
In order to check whether amnioserosa morphogenesis was impaired in cbt mutants, we stained cbt
EP(2 )2237E1
mutant embryos with a anti-Canoe (Cno) antibody, which provides a clear view of the shape of amnioserosal cells. Cell shape changes in the amnioserosa begin with apical constriction of cells at the anterior and posterior ends of this tissue. The middle cells in between the two clusters are elongated perpendicular to the A-P axis, but at the end of DC they are both elongated along the A-P axis and apically constricted .
Examination of cbt EP(2)2237E1
mutant embryos revealed that morphogenesis of the amnioserosa is not affected by loss of cbt function (Figs. 4E-F and data not shown). Only amnioserosa attachment defects are occasionally seen in the mutants (Fig. 4F) .
Cytoskeleton activity at the leading edge is disturbed in cbt mutant embryos
Besides to the temporally ordered redistribution of several cell-surface-associated proteins in the plane of the epithelium, the actin cytoskeleton reorganizes in the DME cells during DC.
This is reflected by the accumulation of large quantities of non-muscle myosin and filamentous actin at the LE, which occurs in large aggregates or puncta (Kaltschmidt et al., 2002; Ricos et al., 1999) . To determine whether this process occurs normally in cbt mutants,
we examined the levels of non-muscle myosin in cbt
mutant embryos and compared them to wild-type embryos. (Fig. 5) . Our results indicate that the aggregates are missing in the mutants, which show a feeble and irregular accumulation of myosin at the LE. This suggests that cbt is required for the cytoskeletal organization of the DME cells during DC. Defects in the accumulation of myosin at the LE during cable assembly have also been observed in embryos homozygous for mutations in members of the JNK cascade and in mutants for Wg signaling (Kaltschmidt et al., 2002; Ricos et al., 1999) .
cbt acts downstream of the JNK cascade
Genetic analyses have demonstrated that the JNK signal transduction cascade has a very important role during DC, regulating its progression and expression of genes at the LE (reviewed by Harden, 2002) . Our analysis of epidermal and cytoskeletal phenotypes of cbt mutant embryos suggested that this gene could be related to the JNK pathway during this process. This prompted us to determine the epistatic relationships between cbt and hemipterous (hep), a JNK pathway component (Glise et al., 1995 ) with en-GAL4 (Fig. 6D) . Thus, all these findings suggest that cbt functions downstream of JNK signaling.
As previously mentioned, our in situ experiments showed that cbt expression is not only lost in the epidermis but also in the yolk cell, in which the JNK cascade has not been reported to be active. It is assumed that prior to DC, JNK signaling is downregulated in the amnioserosa (Reed et al., 2001 ) but as DC approaches to completion, it is upregulated in that tissue (Reed et al., 2004) . Besides, it has been recently published that there are physical interactions between the amnioserosa and the underlying yolk cell, which are mediated by integrins (Narasimha and Brown, 2004; Reed et al., 2004) . These contacts are accomplished by cellular extensions that might facilitate a signaling function between both tissues (Reed et al., 2004) . We therefore asked whether cbt expression could be affected by mutations in the myospheroid (mys) gene, which encodes the βPS integrin (MacKrell et al., 1988) . Our results
show that cbt expression in the yolk cell nuclei is absent in mys 1 mutants, in which apposition of amnioserosa and yolk cell membranes is compromised (Narasimha and Brown, 2004) .
Conversely, cbt expression in the epidermis is not affected (Fig. 6E-F) . Taken together, these results suggest that cbt expression in the yolk nuclei depends on JNK signaling and requires the physical interaction between the yolk cell and the amnioserosa, supporting the hypothesis that a signaling function could exist between both tissues.
cbt regulates dpp expression at the leading edge
Since our previous results indicate that cbt expression is regulated by the JNK cascade, we wanted to know whether mutations in this gene could affect the expression of the two targets of JNK signaling during DC, which are dpp and puc. To test this, we first monitored dpp expression in wild-type and cbt mutant embryos. The wild-type expression of dpp is dynamic through embryogenesis, but in late embryonic stages is evident in two thin stripes (Fig. 7A) , a dorsal stripe located at the LE, and a ventral stripe (Glise and Noselli, 1997; Riesgo-Escovar and Hafen, 1997) . We find that dpp expression is abolished in LE epidermal cells in cbt mutant embryos, although the stripe located more ventrally is not altered (Fig. 7B ). Moreover, we tested dpp expression in arm-GAL4/UAS-cbt embryos finding that ectopic cbt activity leads to an expansion of the domain of dpp expression at the LE (Figs. 7C-D) . Besides, we find that overexpression of cbt with an en-GAL4 driver also induces ectopic expression of dpp (Fig. 7E) . As previously reported, we see in both experiments that only a subpopulation of cells is competent to express dpp (Morel and Martínez-Arias, 2004 ). These data demonstrate that cbt is a positive regulator of dpp expression at the LE in the dorsal
epidermis. An additional evidence indicating that dpp is downstream of cbt is the finding that dpp overexpression with 69B-GAL4 is able to partially rescue the embryonic lethality of the
cbt EP(2)2237E1
allele (see Table 1 ). The second JNK target gene activated in LE cells is puc (Glise et al., 1995; Riesgo-Escovar et al., 1996) . The expression of puc was measured by using a puc-lacZ enhancer trap (Ring and Martínez-Arias, 1993 signaling function between the amnioserosa and the yolk cell, which would account for the JNK-dependent expression of cbt in the yolk cell nuclei.
Role of cabut in dorsal closure
Our phenotypic analysis of cbt mutants shows that this gene is required during Drosophila DC. Embryos homozygous for a cbt loss-of-function allele exhibit abnormal closure, reflected by the presence of dorsal-anterior holes. DC is a very complex morphogenetic movement that requires the combined effects of different tissues and involves activation of cytoskeletal machineries and signaling pathways (Harden, 2002) . Thus, DC results from a sequence of coordinated events, and defects in any of them lead to a failure of the whole process. Our data indicate that cbt mutant embryos show several defects in the DME cells during DC that can be responsible of the closure phenotypes observed. First, the morphology of the DME cells is abnormal in the mutants, since they do not elongate properly. Second, mutations in cbt affect the cytoskeletal machinery in LE cells. During DC, LE cells assemble an actomyosin cable that is necessary to maintain a uniform epithelial advance (Martin and Wood, 2002) . In cbt mutants we observe an aberrant cable assembly, which shows a very feeble accumulation of myosin. Third, the polarization of these cells, reflected by the redistribution of cell-surface-associated proteins along the D-V plane (like FasIII or Dlg), is sometimes affected in cbt mutants. In those cases such proteins are not cleared from the dorsal most edge of the cells as occurs in wild type embryos at the onset of closure. By contrast, morphogenesis of the amnioserosa appear to occur normally in absence of cbt function. Thus, based on the phenotypes seen in cbt mutant embryos, we conclude that cbt is required at different steps in DC. In particular, it is necessary for elongation of the DME cells in the dorso-ventral axis and for the assembly of the actomyosin cable at the LE. Its involvement during polarization of the DME cells is not clear, since the phenotype observed in the mutants is not very strong.
Similar DC phenotypes have been found in mutants lacking components of the JNK cascade (Harden, 2002; Kaltschmidt et al., 2002; Ricos et al., 1999) , suggesting that cbt could be related to JNK signaling. driver Third, analysis of the expression of dpp and puc, two target genes activated in response to JNK signaling in the LE cells during DC (Glise and Noselli, 1997; Martín-Blanco et al., 1998; Riesgo-Escovar and Hafen, 1997; Zeitlinger et al., 1997) , in cbt mutant embryos reveals that dpp but not puc expression is lost in the mutants. Moreover, dpp expression can be induced ectopically by overexpression of cbt. Taken together, our results indicate that cbt acts downstream of the JNK cascade and the AP-1 transcription factor Jun, regulating dpp expression at the LE. Regarding this, we have found putative AP-1 binding sites in the genomic region located upstream of the cbt transcription unit (data not shown). It is tempting to speculate that cbt expression is directly regulated by Jun through binding to that genomic region. Further experiments will be required to confirm this hypothesis.
Wg signaling is also required for DC. Indeed it regulates cytoskeleton activity at the LE and is also required for the polarization of the DME cells (Kaltschmidt et al., 2002; Morel and Martínez-Arias, 2004; Ricos et al., 1999 ). Since we found that polarization of the DME cells is not complete in some cbt mutant embryos, this raised the possibility that cbt might be related to Wg signaling. To test this, we analyzed cbt expression in arm and dsh mutants. Our results show that cbt expression is not affected in the mutants (data not shown), indicating that Wg signaling is not required for cbt expression. This will explain that defects during this polarization of the DME cells are only occasionally observed in cbt mutant embryos, and confirms that the primary role of the JNK cascade is not the polarization of the DME cells.
JNK-dependent expression of cbt in the yolk cell
An interesting observation is that cbt expression in the yolk cell nuclei is also dependent on JNK signaling. Our results show that cbt expression in that tissue is abolished in embryos mutant for JNK components, although there is no reported evidence that JNK signaling is active in the yolk sac. Then, how could this be achieved? It has been reported that the JNK signaling cascade is active in the amnioserosa and the LE of the epidermis at the beginning of DC. Later on, it is downregulated in the amnioserosa but not in the LE cells and, after closure, it seems to be upregulated again in the amnioserosa to trigger its disintegration and death (Reed et al., 2001; . Recent studies have suggested that the yolk cell is also required for DC (Narasimha and Brown, 2004; Reed et al., 2004) . Indeed, an intimate contact between the amnioserosa and this tissue during DC, which is mediated by integrins, is necessary to prevent anoikis of the amnioserosa. One of these studies has shown that there are cellular extensions that allow contact between both tissues, which led to the proposal that these projections may facilitate a signaling function between them (Reed et al., 2004) . Since JNK signaling is active in the amnioserosa during DC, we considered the possibility that this signaling function could explain the JNK-dependent expression of cbt in the yolk cell. Our results show that cbt expression in that tissue is absent in embryos mutant for myospheroid, which encodes the Drosophila βPS integrin (MacKrell et al. 1988 ). In such embryos there are no physical interactions between the amnioserosa and the yolk cell and, in consequence, neither communication nor signaling function between both tissues can exist. It has been proposed that active forms of ecdysone could be transported from the yolk spheres to the amnioserosa (Reed et al., 2004) . Although our results do not explain how this signaling could occur or which molecules could be responsible for it, it is tempting to speculate that cbt activation in the yolk cell nuclei requires communication between both tissues and implicates the transport of molecules. A more detailed study of the dynamic invaginations seen in the yolk sac membrane, the distribution of Cbt or JNK cascade proteins and their transport between both tissues are necessary to confirm this hypothesis.
A model of Cbt function in the epidermis
Although cbt is expressed in the epidermis and the yolk cell nuclei, DC defects observed in cbt mutant embryos could be explained considering that Cbt is only required in the epidermis.
Indeed, we have shown that the embryonic lethality associated to a cbt mutant allele is totally rescued by overexpression of cbt with an epidermal driver, but only partially rescued when using a driver specific for the yolk cell. Then, the function of this gene in the yolk cell is still unknown. Narashima et al. (2004) and Reed et al. (2004) reported that the close apposition of the yolk cell and the amnioserosa is necessary during DC (and germ band retraction). But it remains unclear whether the yolk cell plays an active role during DC or it is only a mechanistic/signaling support to the morphogenesis or survival of the amnioserosa. Further studies will be required to clarify this issue.
As we have shown, the zinc finger protein Cbt is required downstream of JNK signaling to control actomyosin cable assembly at the LE, elongation of the DME cells, but also to maintain dpp expression in those cells. Although our results do not address the molecular mechanism, we have proposed several models to explain one of these functions, such as dpp activation. One possibility is that Cbt directly activates dpp expression by binding to specific enhancers of the gene. In this function Cbt may be acting alone, or it may need putative partners that would cooperate or potentiate its function. Alternatively, we can imagine a different situation where dpp activation is not direct but mediated by another gene that would be activated by Cbt. Moreover, Cbt could also activate the expression of other genes necessary for cable assembly or epidermal cell elongation. Several experiments are in progress in our laboratory to identify possible Cbt partners and other genes that could be related to its function. This will help to unravel the exact mechanism of action that allows Cabut to regulate gene expression and to determine the exact role of this gene during DC. Anti-non muscle myosin II stainings in (A) wild-type and (B) cbt mutant embryos to visualize the contractile cable at the LE. Note the elevated and punctate distribution of myosin in wildtype embryos, which accumulates in large aggregates at the LE. cbt mutant embryos show a feeble and irregular accumulation of myosin at the LE, and the protein is depleted in patches (arrows). Scale bar in A, 100µm (applicable to B). 
